Maximus Inc. (NYSE:MMS) issued an update on its FY17 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.90-3.10 for the period, compared to the Thomson Reuters consensus estimate of $3.10. The company issued revenue guidance of $2.475-2.55 billion, compared to the consensus revenue estimate of $2.59 billion.

Shares of Maximus Inc. (NYSE:MMS) opened at 49.12 on Friday. The stock has a 50 day moving average of $54.11 and a 200 day moving average of $56.12. Maximus Inc. has a one year low of $43.69 and a one year high of $61.68. The stock has a market cap of $3.19 billion, a P/E ratio of 20.07 and a beta of 1.15.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, November 10th. The company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.05. The business earned $623.10 million during the quarter, compared to the consensus estimate of $610.65 million. Maximus had a net margin of 6.91% and a return on equity of 23.89%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.53 earnings per share. Equities analysts expect that Maximus Inc. will post $2.65 EPS for the current fiscal year.

Earnings History and Estimates for Maximus (NYSE:MMS)

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 30th. Shareholders of record on Tuesday, November 15th will be paid a dividend of $0.045 per share. The ex-dividend date is Thursday, November 10th. This represents a $0.18 dividend on an annualized basis and a yield of 0.37%. Maximus’s dividend payout ratio (DPR) is 7.32%.

A number of research analysts have commented on MMS shares. Zacks Investment Research downgraded shares of Maximus from a hold rating to a sell rating in a research note on Wednesday, August 3rd. Maxim Group increased their price objective on shares of Maximus from $71.00 to $74.00 and gave the company a buy rating in a research note on Thursday, August 4th. Finally, Raymond James Financial Inc. downgraded shares of Maximus from an outperform rating to a market perform rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of $63.00.

In related news, CEO Richard A. Montoni sold 25,000 shares of the stock in a transaction dated Thursday, August 25th. The shares were sold at an average price of $58.70, for a total value of $1,467,500.00. Following the sale, the chief executive officer now owns 620,282 shares of the company’s stock, valued at approximately $36,410,553.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President Bruce Caswell sold 30,000 shares of the stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $58.98, for a total transaction of $1,769,400.00. Following the completion of the sale, the president now directly owns 39,386 shares in the company, valued at approximately $2,322,986.28. The disclosure for this sale can be found here. Company insiders own 3.60% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Pacer Advisors Inc. purchased a new stake in Maximus during the second quarter worth $302,000. Hsbc Holdings PLC boosted its stake in Maximus by 8.1% in the second quarter. Hsbc Holdings PLC now owns 6,506 shares of the company’s stock worth $360,000 after buying an additional 485 shares during the period. Profund Advisors LLC boosted its stake in Maximus by 8.2% in the second quarter. Profund Advisors LLC now owns 9,201 shares of the company’s stock worth $509,000 after buying an additional 696 shares during the period. KCG Holdings Inc. purchased a new stake in Maximus during the third quarter worth $572,000. Finally, Ameritas Investment Partners Inc. boosted its stake in Maximus by 2.4% in the second quarter. Ameritas Investment Partners Inc. now owns 15,346 shares of the company’s stock worth $850,000 after buying an additional 360 shares during the period. 99.00% of the stock is currently owned by institutional investors and hedge funds.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.

5 Day Chart for NYSE:MMS

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.